Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04337177Phase 1Active Not Recruiting
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Ewing SarcomaHepatoblastomaMedulloblastoma+3 more
PrincipalinvestigatorStart date: 2021-10-25

Research Network

Collaboration Network

11 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Sarah Cannon Research Institute, Pediatric Hematology & Oncology

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mia Weiss, M.D.

Washington University School of Medicine

Similar
5 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

Kieuhoa Vo, M.D.

UCSF - Mission Bay, Benioff Children's Hospital

Similar
1 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

Patrick Thompson, M.D.

UNC Chapel Hill - North Carolina Cancer Hospital

Similar
1 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

Michael Deel, M.D.

Children's Hospital Medical Center, Cincinnati

Similar
1 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

William Thomas Cash, M.D.

Children's Healthcare of Atlanta - Arthur M. Blank Hospital

Similar
1 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

Alok Kothari, M.D.

Phoenix Children's Hospital

Similar
1 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

Lars Wagner, M.D.

Children's Hospital Medical Center, Cincinnati

Similar
1 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

Aerang Kim, M.D.

Children's National Hospital - Washington, DC

Similar
1 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

Erin Trovillion, M.D.

Atrium Health Levine Children's Hospital - Carolinas Medical Center

Similar
1 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

Kyle Jackson, M.D.

Indiana University School of Medicine, Riley Hospital for Children

Similar
1 trials

Shared therapeutic areas:

Sarcoma, EwingHepatoblastomaMedulloblastoma+3 more

Worked with same sponsors:

Valent Technologies, LLC
Collaborated on 1 trial
Similarity Score64%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04337177Phase 1PrincipalInvestigator

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Ewing SarcomaHepatoblastomaMedulloblastoma+3 more
Active Not Recruiting

All 1 trials loaded